Management of Atropine Therapy in Organophosphate Poisoning

Introduction to Atropine Administration

The American Heart Association recommends that atropine should be escalated until life-threatening muscarinic symptoms resolve, regardless of heart rate, as the therapeutic endpoint is control of bronchorrhea, bronchospasm, and adequate blood pressure, not heart rate normalization 1
Tachycardia may originate from nicotinic receptor overstimulation by the organophosphate itself, not from atropine administration 1

The American College of Cardiology recommends administering 1-2 mg IV for adults (0.02 mg/kg for children, minimum 0.1 mg, maximum single dose 0.5 mg in pediatrics) immediately upon recognition of severe poisoning 2, 1
Double the dose every 5 minutes until full atropinization is achieved, defined as: clear chest on auscultation (resolution of bronchorrhea) 3, heart rate >80/min 3, systolic blood pressure >80 mm Hg 2, dry skin and mucous membranes 3, and mydriasis [1] [2, 1, 3]

Atropine-induced tachycardia is an expected pharmacologic effect and represents adequate muscarinic receptor blockade 1
The risk of undertreating organophosphate poisoning far exceeds the risk of atropine-induced tachycardia—inadequate atropinization leads to respiratory failure and death 1

Pralidoxime reverses nicotinic effects (including muscle weakness and potentially some tachycardia) that atropine cannot address 1
Initial adult dose: 1-2 g IV administered slowly over 15-30 minutes, followed by maintenance infusion of 400-600 mg/hour for adults or 10-20 mg/kg/hour for children 1
Administer benzodiazepines (diazepam first-line or midazolam) for seizures and agitation 2, 1

Early endotracheal intubation is recommended for life-threatening organophosphate poisoning 2, 1
Avoid succinylcholine and mivacurium for intubation as they are metabolized by cholinesterase and are contraindicated 2, 1

Continuous cardiac monitoring to detect dysrhythmias, not to limit atropine dosing 1
Serial respiratory assessments every 5-10 minutes during escalation phase 1
Maintain close observation for at least 48-72 hours as delayed complications and relapses can occur, especially with ingested organophosphates due to continued absorption from the GI tract 1